News 2017-02-17
Porton’s Annual Senior Management Working Conference.
Chongqing,China,February 17,2017: Porton Fine Chemicals, Ltd. held its annual senior management working conference on February 17, 2017. Led by Chairman Oliver Ju and President Andrew Xu, senior executives from the Company’s R&D, Manufacturing Operations, Planning, Business Development and Key Account Management functions and overseas subsidiaries reviewed the Company’s progress made during 2016 and forward plans for 2017. Oliver Ju and Andrew Xu lauded the efforts of Porton’s employees towards achievement of FY 2016 revenue targets, and summarized the Company’s strategic initiatives for continued growth in FY 2017 and beyond.
Others
More
News 2026-08-05
Porton Advanced Secures Drug Manufacturing License (Class C), Expanding CDMO Services to Commercialization
Porton Advanced Solutions Ltd. has officially been granted a Drug Manufacturing License (Class C) by the National Medical Products Administration (NMPA). This milestone qualifies Porton Advanced to undertake commercial contract manufacturing for Cell and Gene Therapy (CGT) products, extending its CDMO services from process development and clinical production through to the commercialization stage.
News 2026-07-08
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
Porton Advanced’s UC-MSCs Cell Bank for Exosome Manufacturing Receives U.S. FDA Drug Master File (DMF) Acceptance
